文献速递产科母胎医学

胎儿多普勒血流测定、胎儿生长轨迹及母血清生物标志物对短期不良围产结局的预测价值:DRIGITAT 研究的二次分析

Predictive value of fetal Doppler velocimetry, fetal growth trajectory and maternal serum biomarkers for short-term adverse perinatal outcome: secondary analysis of DRIGITAT study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-07-11

该研究为 DRIGITAT 研究的事后分析,纳入 440 例 32.0–36.9 周小于胎龄儿(SGA)单胎妊娠,评估胎盘功能不全标志物对复合不良围产结局(CAPO)的预测价值。最终模型纳入入组时估计胎儿体重、入组时 sFlt-1/PlGF 比值及孕期最高脐脑比(UCR),曲线下面积为 0.75(95% CI 0.70–0.81),假阳性率 5%、10%、25% 时敏感度分别为 35.6%、44.2%、63.5%。发生 CAPO 的新生儿出生孕周及出生体重均较低。

要点

  • 入组时体重指数、孕周、估计胎儿体重、sFlt-1/PlGF 比值、子痫前期发生、最高 UCR 及胎儿生长速度均与 CAPO 显著相关。
  • 最终预测模型含入组时估计胎儿体重、入组时 sFlt-1/PlGF 比值及孕期最高 UCR,AUC 为 0.75(95% CI 0.70–0.81)。
  • 假阳性率 5%、10%、25% 时模型对 CAPO 的敏感度分别为 35.6%、44.2%、63.5%。

核心结论

  • 在 SGA 人群中,入组时母亲体重指数、孕周、估计胎儿体重及 sFlt-1/PlGF 比值、孕期最高 UCR、子痫前期发生及胎儿生长速度均与 CAPO 相关。
  • 包含入组时估计胎儿体重、入组时 sFlt-1/PlGF 比值及最高 UCR 的模型对 CAPO 预测最有效。

研究设计与样本

  • DRIGITAT 研究的事后分析,该研究为荷兰多中心队列研究,纳入 690 例 32.0–36.9 周 SGA 单胎妊娠,时间范围为 2018 年至 2022 年。
  • 本分析纳入 440 例有生物标志物测量且未因反复异常多普勒血流而随机提前于 36 周前分娩的参与者。

主要发现

  • 入组时母亲体重指数(P = 0.02)、入组时孕周(P ≤ 0.001)、入组时估计胎儿体重(P ≤ 0.001)、入组时 sFlt-1/PlGF 比值(P ≤ 0.001)、子痫前期发生(P ≤ 0.001)、孕期任一时刻最高 UCR 值(P ≤ 0.001)及胎儿生长速度(P ≤ 0.001)均与 CAPO 显著相关。
  • 逻辑回归模型中,入组时母亲体重指数、入组时孕周、子痫前期发生及胎儿生长速度因与其他变量相关而未增加模型预测价值。
  • 最终预测模型(含入组时估计胎儿体重、入组时 sFlt-1/PlGF 比值及任一时刻最高 UCR 值)的受试者工作特征曲线下面积为 0.75(95% CI 0.70–0.81)。
  • 假阳性率 5%、10%、25% 时,预测模型对 CAPO 的敏感度分别为 35.6%、44.2%、63.5%。
  • 发生 CAPO 的新生儿出生孕周中位数及出生体重均低于未发生 CAPO 者(分别为 37.0 周 vs 38.3 周和 1.993 kg vs 2.518 kg)。

关键数值与推荐

  • CAPO 定义为胎儿死亡、出生时不良状况、主要新生儿疾病和/或新生儿死亡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the predictive value of markers of placental insufficiency and fetal growth restriction for a composite adverse perinatal outcome (CAPO) in a small-for-gestational-age (SGA) population. We also aimed to identify profiles that discriminate fetuses as low or high risk for CAPO, and to evaluate the association of onset of labor and mode of birth with CAPO. METHODS: This was a preplanned post-hoc analysis of the DRIGITAT study, a Dutch multicenter cohort study of management strategy in 690 singleton SGA pregnancies at 32.0-36.9 weeks' gestation, between 2018 and 2022. We used data from 440 participants with available biomarker measurements, who were not randomized for immediate birth before 36 weeks' gestation on the basis of recurrent abnormal Doppler velocimetry. We defined CAPO as fetal death, adverse condition at birth, major neonatal morbidity and/or neonatal mortality. We analyzed the predictive value for CAPO of maternal body mass index (BMI), gestational age, estimated fetal weight (EFW) and soluble fms-like tyrosine kinase-1 to placental growth factor ratio (sFlt-1/PlGF ratio) at inclusion, development of pre-eclampsia, highest value of the umbilicocerebral ratio (UCR) and fetal growth velocity. We also used these variables to develop a prediction model for CAPO using forward stepwise logistic regression to emulate real-world clinical evaluation. RESULTS: In this population of 440 singleton SGA pregnancies, maternal BMI at inclusion (P = 0.02), gestational age at inclusion (P ≤ 0.001), EFW at inclusion (P ≤ 0.001), sFlt-1/PlGF ratio at inclusion (P ≤ 0.001), development of pre-eclampsia (P ≤ 0.001), highest value of the UCR measured at any time during pregnancy (P ≤ 0.001) and fetal growth velocity (P ≤ 0.001) were all associated significantly with CAPO. When combined into a prediction model using logistic regression analysis, maternal BMI at inclusion, gestational age at inclusion, development of pre-eclampsia and fetal growth velocity did not add to the predictive value of the model, because of their correlation with other variables. The area under the receiver-operating-characteristics curve of the final prediction model, comprising EFW at inclusion, sFlt-1/PlGF ratio at inclusion and the highest UCR value at any time, was 0.75 (95% CI, 0.70-0.81). At false-positive rates of 5%, 10% and 25%, the sensitivities of the prediction model for CAPO were 35.6%, 44.2% and 63.5%, respectively. The median gestational age at birth and birth weight were lower in neonates that experienced CAPO compared with those that did not (37.0 weeks vs 38.3 weeks and 1.993 kg vs 2.518 kg, respectively). Vaginal birth occurred in 69.3% of our population. In the group that experienced CAPO, a higher number of (emergency) Cesarean sections were performed. CONCLUSIONS: In a SGA population, maternal BMI, gestational age, EFW and sFlt-1/PlGF ratio at inclusion, highest UCR at any time, development of pre-eclampsia and fetal growth velocity were associated with CAPO. A model incorporating EFW at inclusion, sFlt-1/PlGF ratio at inclusion and highest UCR was most effective for the prediction of CAPO. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kamphof HD, Marijnen MC, Damhuis SE, et al. Predictive value of fetal Doppler velocimetry, fetal growth trajectory and maternal serum biomarkers for short-term adverse perinatal outcome: secondary analysis of DRIGITAT study. Ultrasound Obstet Gynecol. 2025. PMID: 40641303. doi:10.1002/uog.29266

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。